KRN7000 applied to asthma research

Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production

Exploiting the innate immune system to control allergic asthma

A CD1d-Dependent Antagonist Inhibits the Activation of Invariant NKT Cells and Prevents Development of Allergen-Induced Airway Hyperreactivity

Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma

Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma

Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases

Alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation

Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide

 

 

 

 

 

New 7DW8-5 glycolipid

7DW8-5

Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch

 

Meet Funakoshi Company
at the following meetings:

The 21st Annual Meeting of Japanese Assocation of Cancer Immunology
Chiba, Japan
June 28-30, 2017

The Japanese Society for Genome Editing
Osaka, Japan
June 28-30, 2017

The 36th Annual Meeting of Japanese Association of Forensic Toxicology
July 6-7, 2017

The 76th Annual Meeting of the Japanese Cancer Association
Yokohama, Japan
September 28-30, 2017

NIH Festival
Bethesda, Maryland
September 2017

ASCB
Philadelphia, PA
December 2-6, 2017